| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P50 | author | Bruno Vellas | Q66877204 |
| P2093 | author name string | Matteo Cesari | |
| Gabor Abellan van Kan | |||
| Bertrand Fougère | |||
| P2860 | cites work | The mortality rate as a function of accumulated deficits in a frailty index | Q78499548 |
| Protein oxidation and aging | Q79336883 | ||
| Detection of growth hormone abuse in sport | Q79879523 | ||
| Antagonism of myostatin enhances muscle regeneration during sarcopenia | Q80434452 | ||
| Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation | Q80609169 | ||
| Cytokine-related aging process | Q80837302 | ||
| Oxidative stress and the mitochondrial theory of aging in human skeletal muscle | Q80872046 | ||
| The origins of age-related proinflammatory state | Q81079607 | ||
| Destabilization of the neuromuscular junction by proteolytic cleavage of agrin results in precocious sarcopenia | Q84874688 | ||
| Radioimmunoassays for type III procollagen amino-terminal peptides in humans | Q93594471 | ||
| Sarcopenia and age-related endocrine function | Q21296731 | ||
| To build a synapse: signaling pathways in neuromuscular junction assembly | Q24631081 | ||
| Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People | Q24633789 | ||
| Creatine and creatinine metabolism | Q28140735 | ||
| Biomarkers and surrogate endpoints: preferred definitions and conceptual framework | Q28203935 | ||
| Frailty in older adults: evidence for a phenotype | Q28205094 | ||
| Invited review: Aging and sarcopenia | Q28206542 | ||
| A comparison of two approaches to measuring frailty in elderly people | Q28236735 | ||
| Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member | Q28237287 | ||
| Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome | Q28299737 | ||
| Neurotrypsin cleaves agrin locally at the synapse | Q28513643 | ||
| Activity-induced synaptic capture and exocytosis of the neuronal serine protease neurotrypsin | Q28585465 | ||
| Change in Muscle Strength Explains Accelerated Decline of Physical Function in Older Women With High Interleukin-6 Serum Levels | Q29040972 | ||
| Interventions to prevent disability in frail community-dwelling elderly: a systematic review | Q30856579 | ||
| Validation of the growth hormone (GH)-dependent marker method of detecting GH abuse in sport through the use of independent data sets | Q31116547 | ||
| Age-related sarcopenia in humans is associated with reduced synthetic rates of specific muscle proteins | Q41709939 | ||
| Purification and characterization of the N-terminal propeptide of human type III procollagen | Q42008279 | ||
| A comprehensive and non-prefractionation on the protein level approach for the human urinary proteome: touching phosphorylation in urine | Q43148431 | ||
| The effects of supplementation with creatine and protein on muscle strength following a traditional resistance training program in middle-aged and older men. | Q43176562 | ||
| Longitudinal changes in basal metabolism in man | Q43497491 | ||
| In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue | Q43607247 | ||
| Increase in oxidative damage to lipids and proteins in skeletal muscle of uremic patients | Q44032617 | ||
| Functional improvement of dystrophic muscle by myostatin blockade. | Q44234792 | ||
| The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. | Q44968760 | ||
| Similar acute molecular responses to equivalent volumes of isometric, lengthening, or shortening mode resistance exercise | Q46079796 | ||
| Influence of ethnicity on IGF-I and procollagen III peptide (P-III-P) in elite athletes and its effect on the ability to detect GH abuse | Q46213933 | ||
| Pharmacodynamics of growth hormone abuse biomarkers and the influence of gender and testosterone: a randomized double-blind placebo-controlled study in young recreational athletes | Q46670011 | ||
| Inflammatory markers and incident mobility limitation in the elderly | Q47313143 | ||
| Total-body creatine pool size and skeletal muscle mass determination by creatine-(methyl-D3) dilution in rats | Q47321337 | ||
| The contribution of reactive oxygen species to sarcopenia and muscle ageing. | Q48031117 | ||
| Vitamin D receptor expression in chicken muscle tissue and cultured myoblasts | Q48711027 | ||
| The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins | Q33256124 | ||
| Transcriptional targets of the vitamin D3 receptor-mediating cell cycle arrest and differentiation | Q33538032 | ||
| The effects of age on skeletal muscle and the phosphocreatine energy system: can creatine supplementation help older adults | Q33594432 | ||
| Muscle regeneration in the prolonged absence of myostatin | Q33830785 | ||
| Sarcopenia and physical frailty: two sides of the same coin | Q33958411 | ||
| Induction of cachexia in mice by systemically administered myostatin. | Q33959328 | ||
| Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases | Q34040980 | ||
| Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study | Q34126129 | ||
| Inhibition of myostatin in adult mice increases skeletal muscle mass and strength | Q34174098 | ||
| Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions. | Q34234465 | ||
| A comprehensive map of the human urinary proteome | Q34424829 | ||
| Sarcopenia--consequences, mechanisms, and potential therapies | Q35093935 | ||
| Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report | Q35739002 | ||
| Inflammatory mediators in the elderly | Q35766426 | ||
| Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia | Q36039024 | ||
| Challenges in detecting the abuse of growth hormone in sport | Q36195365 | ||
| Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis | Q36249296 | ||
| Effect of inflammation on the aging microcirculation: impact on skeletal muscle blood flow control | Q36447822 | ||
| The underappreciated role of muscle in health and disease | Q36588837 | ||
| Adipose tissue-derived factors: impact on health and disease | Q36631232 | ||
| Testosterone improves the regeneration of old and young mouse skeletal muscle | Q36686910 | ||
| Age-related changes in oxidative capacity differ between locomotory muscles and are associated with physical activity behavior | Q37051940 | ||
| Elevated serum advanced glycation end products and poor grip strength in older community-dwelling women | Q37103996 | ||
| Oxidative protein damage is associated with poor grip strength among older women living in the community | Q37105406 | ||
| Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength | Q37381535 | ||
| N-terminal propeptide of type III procollagen as a biomarker of anabolic response to recombinant human GH and testosterone | Q37417449 | ||
| Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. | Q37634981 | ||
| Clinical trials on sarcopenia: methodological issues regarding phase 3 trials | Q37705986 | ||
| Low testosterone in men with type 2 diabetes: significance and treatment | Q37885604 | ||
| Oxidative stress, frailty and cognitive decline | Q37956881 | ||
| Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders | Q38155361 | ||
| Specific proteolytic cleavage of agrin regulates maturation of the neuromuscular junction | Q39639185 | ||
| Role of vitamin D in skeletal muscle function | Q39748619 | ||
| Human aging, muscle mass, and fiber type composition | Q40378260 | ||
| What is sarcopenia? | Q40378366 | ||
| Sarcopenia and age-related changes in body composition and functional capacity | Q40873939 | ||
| Urine proteomics for profiling of human disease using high accuracy mass spectrometry | Q41378863 | ||
| Sarcopenia: origins and clinical relevance | Q41481490 | ||
| The biosynthesis of collagen and its disorders (first of two parts). | Q41643900 | ||
| The effect of sports injury on insulin-like growth factor-I and type 3 procollagen: implications for detection of growth hormone abuse in athletes. | Q51959514 | ||
| Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. | Q52707875 | ||
| Relationships between in vivo and in vitro measurements of metabolism in young and old human calf muscles. | Q54234886 | ||
| Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. | Q54537821 | ||
| Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. | Q55035867 | ||
| Insulin Resistance and Inflammation as Precursors of Frailty | Q59442589 | ||
| Effects of a Physical Activity Intervention on Measures of Physical Performance: Results of the Lifestyle Interventions and Independence for Elders Pilot (LIFE-P) Study | Q59538274 | ||
| POINT: IGF IS THE MAJOR PHYSIOLOGICAL REGULATOR OF MUSCLE MASS | Q60275373 | ||
| Inflammatory Markers and Loss of Muscle Mass (Sarcopenia) and Strength | Q60298077 | ||
| Prolonged absence of myostatin reduces sarcopenia | Q60462848 | ||
| Within-Subject Variability and Analytic Imprecision of Insulinlike Growth Factor Axis and Collagen Markers: Implications for Clinical Diagnosis and Doping Tests | Q60777449 | ||
| Influence of Demographic Factors and Sport Type on Growth Hormone-Responsive Markers in Elite Athletes | Q60777459 | ||
| Comparison of Frailty Indicators Based on Clinical Phenotype and the Multiple Deficit Approach in Predicting Mortality and Physical Limitation | Q61567883 | ||
| Serum type III procollagen propeptide levels in acromegalic patients | Q69890298 | ||
| Relationship of procollagen type III propeptide-related antigens in serum to somatic growth in healthy children and patients with growth disorders | Q69943516 | ||
| Did you say 'sarcopenia'? | Q70558998 | ||
| Effect of aging on energy-rich phosphagens in human skeletal muscles | Q71357481 | ||
| Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males | Q73351516 | ||
| Aging of skeletal muscle: a 12-yr longitudinal study | Q73630942 | ||
| Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group | Q73687529 | ||
| Intracellular signaling specificity in skeletal muscle in response to different modes of exercise | Q73742313 | ||
| Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation | Q74281358 | ||
| A characterization of vitamin D-independent intestinal calcium absorption in the osteopetrotic (op/op) mouse | Q78109344 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | sarcopenia | Q1787939 |
| P304 | page(s) | 103-110 | |
| P577 | publication date | 2015-03-17 | |
| P1433 | published in | Translational neuroscience | Q27723509 |
| P1476 | title | Identification of biological markers for better characterization of older subjects with physical frailty and sarcopenia | |
| P478 | volume | 6 |
| Q91660758 | A panel of multibiomarkers of inflammation, fibrosis, and catabolism is normal in healthy centenarians but has high values in young patients with myocardial infarction |
| Q51762251 | A review of telomere length in sarcopenia and frailty. |
| Q93143651 | Balancing Weight Loss and Sarcopenia in Elderly Patients With Peripheral Artery Disease |
| Q57159234 | Biological Processes and Biomarkers Related to Frailty in Older Adults: A State-of-the-Science Literature Review |
| Q91251493 | Defining frailty for healthcare practice and research: A qualitative systematic review with thematic analysis |
| Q47178938 | Editorial: Weight Loss is a Major Cause of Frailty |
| Q40233897 | Effects of 5 Weeks of Bench Press Training on Muscle Synergies: A Randomized Controlled Study. |
| Q104277349 | Exercise and Nutrition for Healthy AgeiNg (ENHANce) project - effects and mechanisms of action of combined anabolic interventions to improve physical functioning in sarcopenic older adults: study protocol of a triple blinded, randomized controlled t |
| Q93035512 | If my muscle could talk: Myokines as a biomarker of frailty |
| Q99726160 | Protein Intake and Frailty: A Matter of Quantity, Quality, and Timing |
| Q91193163 | Sedentary Time, Physical Activity, Fitness, and Physical Function in Older Adults: What Best Predicts Sleep Quality? |
| Q90694506 | The Effect of Nordic Walking Training with Poles with an Integrated Resistance Shock Absorber on the Functional Fitness of Women over the Age of 60 |
| Q88965091 | The essence of frailty: A systematic review and qualitative synthesis on frailty concepts and definitions |
Search more.